Company News
Globus Medical Gains 1% After EU CE Approval
Globus Medical shares rose ~1% in after‑hours trading Thursday after CE mark approval for Excelsius3D in EU and UK.
The Excelsius3D mobile platform combines 3D cone‑beam CT, 2D fluoroscopy and digital